Vicat (VCT) Q1 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 TU earnings summary
24 Dec, 2025Executive summary
Q1 2025 organic sales remained stable at €886 million, with resilience in Western Europe, especially Switzerland and Italy, offsetting slowdowns in India and Africa; strong performance in Egypt and improved business in Brazil.
FY 2025 guidance confirmed, focusing on like-for-like sales growth, low single-digit EBITDA growth, and climate initiatives, including public consultation for major CCS projects.
Integration of Cermix with VPI strengthens the construction chemicals business in France, contributing €7 million to revenue.
Financial highlights
Group sales reached €886 million, down 2.7% reported and -0.2% like-for-like, mainly due to negative currency effects totaling €30 million (–3.3%) from Turkish lira, Egyptian pound, and Brazilian real.
Price increases offset lower volumes, and Cermix integration added €7 million to revenue.
Cement sales up 0.5% like-for-like despite a 6.8% volume drop, mainly in India; prices solid in developed markets.
Net capital expenditures are expected to be around €280 million for 2025.
Outlook and guidance
2025 guidance confirmed: like-for-like sales growth, low single-digit EBITDA growth, and EBITDA margin target of at least 20% for 2025–2027.
Leverage ratio targeted at 1.3x by end-2025 and below 1.0x by end-2027.
Acceleration in performance expected in H2 2025, supported by the CAN6 kiln in Senegal and stabilizing energy costs.
Guidance does not factor in the macro impact of a prolonged trade conflict.
Latest events from Vicat
- Sales +3.3% LFL, EBITDA +3.7% LFL, strong cash flow, and major decarbonization progress.VCT
H2 202517 Feb 2026 - EBITDA up 12.3% and organic sales up 4.8% in H1 2024, led by US and emerging markets.VCT
H1 20242 Feb 2026 - 3.3% organic sales growth, EBITDA targets confirmed, US and emerging markets offset Europe.VCT
Q3 2024 TU16 Jan 2026 - Record EBITDA and cash flow, with US growth and climate progress offsetting European weakness.VCT
H2 202410 Dec 2025 - Q3 2025 saw 4.9% organic sales growth and strategic progress despite FX headwinds.VCT
Q3 2025 TU13 Nov 2025 - Stable sales and improved net income, with 2025 EBITDA growth guided at +2–5% like-for-like.VCT
H1 202520 Oct 2025